This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Repeated and repeating steroid injection in tennis elbow

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

Corticosteroid injection in tennis elbow

  • while corticosteroid injections have been shown to improve short-term pain relief (4 to 6 weeks) compared with both placebo and bracing, there is evidence that the long-term outcome following corticosteroid injection for treatment of tennis elbow may be worse than no treatment or physiotherapy alone. (1)
  • hydrocortisone acetate mixed with local anaesthetic may be used, and long acting steroids should be avoided as there is a risk of skin atrophy
  • repeated corticosteroid injections should be avoided (1)

Care must be taken to avoid both the nerve medially (paralysis) and subcuticular adipose tissue (necrosis) (2)

1. Gaujoux-Viala C et al. Efficacy and safety of steroid injections for shoulder and elbow tendonitis: a meta-analysis of randomised controlled trials. Ann Rheum Dis. 2009 Dec;68(12):1843-9.

2. Coombes BK et al. Efficacy and safety of corticosteroid injections and other injections for management of tendinopathy: a systematic review of randomised controlled trials. Lancet. 2010 Nov 20;376(9754):1751-67.


Related pages

Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.